Trial intelligence / Profile preview

Oliceridine vs morphine for analgesia in severe traumatic brain injury

ChiCTR2400086779Phase 4Recruiting

Sponsor
Jining First People's Hospital
Start
Jul 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of oliceridine in traumatic brain injury (TBI) (2 arms), sponsored by Jining First People's Hospital. Primary endpoints: Duration of ventilator use and Inhibition of respiratory function. Started Jul 2024; status: recruiting.

02

Drugs

oliceridine
03

Conditions

traumatic brain injury (TBI)

Beyond the preview

Go deeper on ChiCTR2400086779.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400086779.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call